CD38 and CD47 Targeted Alpha Therapy (TAT): Potent Alternatives to CD33 in AML
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Radiopharmaceutical Chemistry and Applications
Acute Myeloid Leukemia Research
Protein Degradation and Inhibitors
Publication details
- Journal / source
- Journal of medical imaging and radiation sciences
- Volume
- 57
- Issue
- 2
- Pages
- 102233–102233
- Publication date
- 1 March 2026
- Language
- EN